ADHD and Autism Show Elevated Prevalence in Early-Onset Type 2 Diabetes Under Age 20

Researchers matched 3.4 million pairs from the TriNetX US collaborative network across 10-year age bands, comparing neurodiversity rates in newly diagnosed type 2 diabetes patients against controls adjusted for age, sex, ethnicity, and birth year. Prevalence of ADHD and autism declined sharply with age in both groups yet remained consistently higher in the diabetes cohort, with the largest gaps before age 20; dyslexia showed a stable twofold elevation independent of age. The conference presentation at EASD 2026 highlights how neurodivergent traits may compound challenges in glycemic management and healthcare navigation, amplifying risks of early complications from prolonged hyperglycemia exposure.

This pattern aligns with known overlaps between executive function deficits in ADHD or autism and the self-management demands of diabetes regimens, suggesting shared pathways involving inflammation, medication effects, or socioeconomic barriers that prior smaller studies in Diabetes Care have flagged but not quantified at this scale. Integrated care models, already piloted in UK and US pediatric endocrinology, could address these gaps by embedding behavioral supports rather than treating conditions in silos.

Remaining questions include whether neurodiversity precedes diabetes onset or emerges from shared risk factors, and whether tailored interventions improve HbA1c or reduce hospitalizations; the current retrospective design cannot establish causality or rule out diagnostic bias in younger cohorts. A prospective registry linking neurodevelopmental assessments to diabetes outcomes would clarify these links.